The global Dementia - Alzheimer’s Disease Market is at a historic crossroads in 2026. After decades of research focused solely on symptomatic relief, the market has officially transitioned into the era of Disease-Modifying Therapies (DMTs). This shift is fundamentally altering the economic landscape of neurology, moving from low-cost generic management to high-value, specialized biolo... https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/